Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0000950123-06-003802
Filing Date
2006-03-28
Accepted
2006-03-28 17:03:40
Documents
6

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.3 TO FORM S-1 w15453a3sv1za.htm S-1/A 1388348
2 EX-1.1: FORM OF UNDERWRITING AGREEMENT w15453a3exv1w1.txt EX-1.1 90871
3 EX-10.17: FORM OF INCENTIVE PLAN w15453a3exv10w17.htm EX-10.17 114022
4 EX-23.2: CONSENT OF PRICEWATERHOUSECOOPERS LLP w15453a3exv23w2.txt EX-23.2 785
6 GRAPHIC w15453a3w1545300.gif GRAPHIC 3159
7 filename7.txt CORRESP 2118
  Complete submission text file 0000950123-06-003802.txt   1602124
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850 240-599-4500
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

EIN.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-130759 | Film No.: 06715732
SIC: 2834 Pharmaceutical Preparations